Results showed a trend towards increased tumoral immune activity and increased peripheral blood cytokine/chemokines levels in a cavrotolimod dose-dependent manner [87].” This was removed: “Of four subjects with MCC, a difficult cancer to treat, two patients had sustained reduction in tumor size 12 to 24 weeks after starting therapy [89].
← all excerpts
Correction: Holmes, T.R.; Paller, A.S. Gene Regulation Using Spherical Nucleic Acids to Treat Skin Disorders. <i>Pharmaceuticals</i> 2020, <i>13</i>, 360.
1
—
—